Hi- I'm new to this gruop, and would love to hear someones opinions on the below CT scan report from the radiologist.
I have a bronchoscope scheduled for Friday and Pulminologist said she would have results for me, likely late next week.
41 year old non-smoker male.
CT CHEST WITHOUT CONTRAST dated 4/20/2022 9:07 AM
CLINICAL HISTORY: Cough, persistent.
COMPARISON: Chest x-ray 3/29/2022.
PROCEDURE COMMENTS: CT of the chest was performed without IV contrast. This
examination was performed with automated exposure control to minimize patient
radiation exposure.
FINDINGS:
Lungs: The right lower lobar bronchus, at the level of the superior segmental
bronchus, contains an endobronchial lesion with subsequent peripheral mucous
plugging and basal segmental atelectasis. Small regions of tree-in-bud
inflammatory infiltrate are also seen through the superior segment of the right
lower lobe.
Posterior left lower lobe pulmonary nodule, 3 mm, series 3 image 78. No other
pulmonary nodules, focal airspace consolidations or masses. No pleural effusions
or pneumothorax. The central airways are patent.
Lymph nodes: Noncontrast technique limits evaluation for hilar lymphadenopathy.
Within these constraints, no supraclavicular, axillary, mediastinal, or hilar
lymphadenopathy is identified.
Mediastinum: The heart size is within normal limits. No pericardial effusion.
Small air-fluid level in the distal thoracic esophagus.
Chest wall and spine: No acute osseous abnormality.
Upper abdomen: The upper abdominal viscera are unremarkable.
IMPRESSION:
1. The right lower lobar bronchus is occluded by an endobronchial lesion.
Further evaluation with endobronchial/bronchoscopic tissue sampling is advised.
The age of the patient and the endobronchial location raises the possibility of
pulmonary carcinoid.
2. The right lower lobe basal segments demonstrate atelectasis with scattered
tree-in-bud inflammatory infiltrates through the superior segment of the right
lower lobe.
3. No definite lymphadenopathy of the chest.
4. The small, 3 mm, left lower lobe pulmonary nodule should remain under
longer-term follow-up. To be based upon the patient's subsequent oncological
profile.
